Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.7250
-0.0250 (-3.33%)
Dec 31, 2025, 12:28 PM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 10.97 million as of December 31, 2025. Its market cap has increased by 72.34% in one year.
Market Cap
10.97M
Enterprise Value
10.84M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.73
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 10.97M, a decrease of -78.79%. That is a compound annual growth rate of -25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |